Results 101 to 110 of about 29,491 (205)

Diverse DTPA‐chelated lanthanides with relevance for nuclear medicine bound to an engineered lipocalin reveal conserved ligand geometry

Acta Crystallographica Section F, Volume 82, Issue 9, Page 301-311, September 2026.
Structural and binding studies of the engineered lipocalin CL31d towards the chelate complexes of 11 different lanthanide and main‐group metal(III) ions, whose radioisotopes are useful for nuclear medicine, with a functionalized DTPA revealed a surprisingly broad tolerance towards varying ionic radii, thus enabling flexible radionuclide‐targeting ...
Alina Mirwald, Andreas Eichinger, Arne Skerra   +2 more
wiley   +1 more source

Comparison of four different in vitro assays for prediction of potential RBC antibody clinical significance

Transfusion, Volume 66, Issue 9, Page 1830-1839, September 2026.
Abstract Background The monocyte monolayer assay (MMA) uses monocytes, but it is known that antibody‐mediated hemolysis occurs in macrophages. Whether the use of macrophages would improve the predictive capacity of the MMA is unclear. Also, it is unclear if RBC alloantibodies contribute to hemolysis via antibody‐dependent cellular cytotoxicity (ADCC ...
Yeniley Ruiz Noa, Clémence Salou, Myriam Beshai, Selena Y. Cen, Lindsay K. Hillis, Katrina Billingsley, Donald R. Branch   +6 more
wiley   +1 more source

Medicinal and Crop Protection Chemistry: Breaking Barriers, Building Synergies

ChemMedChem, Volume 21, Issue 16, 27 August 2026.
A unified view of medicinal and crop protection chemistry reveals shared scientific progress, common challenges, and new opportunities for cross‐disciplinary collaboration. Bridging expertise across both fields could accelerate innovation and actively encourage more sustainable solutions.
Giulia Cazzaniga, Giusy L. Fratello, Alexander T. Apostle, Roberto Orru, David M. Barber, Silvia Gazzola   +5 more
wiley   +1 more source

Lead-212 Radiopharmaceuticals for Receptor-Targeted Radionuclide Therapy [PDF]

Journal of Mazandaran University of Medical Sciences
Receptor-targeted radionuclide therapy (RTRT) combines the power of particle-emitting radionuclides with the receptor-targeting capabilities of biomolecules, including antibodies and peptides.
Solmaz Mojarad-Jabali, Sajjad Molavipordanjani   +1 more
doaj  

RADIATION-HYGIENIC JUSTIFICATION OF OUTPATIENT RADIONUCLIDE THERAPY

Радиационная гигиена, 2015
The possibility of the use of the different therapeutic radiopharmaceuticals labeled with one of the 19 β-γ-emitting radionuclides or 6 α-β-γ-emitting radionuclides in the outpatient regime was identified in the estimateinvestigations.
B. Ja. Narkevich, S. V. Shiryaev, A. N. Klyopov, N. N. Lipanova, Yu. V. Lysak   +4 more
doaj  

The current status and prospects of theranostic in targeted radionuclide therapy

肿瘤影像学
Targeted radionuclide therapy (TRT) leveraging the unique properties of radioactive pharmaceuticals to concentrate therapeutic effects within tumor tissues.
DING Ying, YANG Hui
doaj  

Targeted Radionuclide Therapy: Current Landscape and Combination Approaches to Improve Oncology Outcomes. [PDF]

Clin Cancer Res
Nonnekens J, Byers LA, Chauhan A, George DJ, Hicks RJ, Weber WA.   +5 more
europepmc   +1 more source

Preclinical efficacy and dosimetry of CD44v6-directed terbium-161 radionuclide therapy. [PDF]

Theranostics
Gustafsson A, Mortensen ACL, Rondahl V, Xu T, Bratteby K, Bernhardt P, Nestor M.   +6 more
europepmc   +1 more source

FAP-Targeted Radionuclide Therapy: Mechanisms, Clinical Applications, and Combination Strategies. [PDF]

Biomedicines
Arçay Öztürk A, Saúde-Conde R, Gebruers J, Flamen P.   +3 more
europepmc   +1 more source

Pregnancy in a patient with metastatic functioning midgut neuroendocrine tumor receiving lanreotide after peptide receptor radionuclide therapy. [PDF]

Arch Endocrinol Metab
Silva BTD, Maia A, Pereira MT, Santos S, Garrido S, Vilaverde J, Moreira MS, Pinto C, Santos AP, Dores J.   +9 more
europepmc   +1 more source